Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Circulation
|
February 9, 2005
Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study
Marco Valgimigli, Claudio Ceconi, Patrizia Malagutti, et al.
Trials
|
February 20, 2016
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial
Antonio Maria Leone, Domenico D'Amario, Luciana Teofili, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
May 11, 2023
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
Juan Tamargo, Stefan Agewall, Claudio Borghi, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
December 2, 2011
[Preventive cardiology: comparisons of European and Italian projects with the Cardiac Units from Emilia Romagna region. A workshop of IACPR/GICR - Emilia Romagna]
Massimo F Piepoli, Antonio Brambilla, Lorenzo Brambilla, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 13, 2018
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review
Alexander Vonbank, Heinz Drexel, Stefan Agewall, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 21, 2024
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023
Juan Tamargo, Stefan Agewall, Claudio Borghi, et al.
European Heart Journal
|
January 13, 2017
Comprehensive efforts to increase adherence to statin therapy
Alexander Vonbank, Stefan Agewall, Keld Per Kjeldsen, et al.
European Heart Journal
|
November 11, 2017
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Alexander Niessner, Juan Tamargo, Lorenz Koller, et al.
European Heart Journal
|
September 22, 2022
Sex differences in arterial hypertension
Eva Gerdts, Isabella Sudano, Sofie Brouwers, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 29, 2022
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Juan Tamargo, Keld Per Kjeldsen, Eva Delpón, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Circulation
|
February 9, 2005
Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study
Marco Valgimigli, Claudio Ceconi, Patrizia Malagutti, et al.
Trials
|
February 20, 2016
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial
Antonio Maria Leone, Domenico D'Amario, Luciana Teofili, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
May 11, 2023
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
Juan Tamargo, Stefan Agewall, Claudio Borghi, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
December 2, 2011
[Preventive cardiology: comparisons of European and Italian projects with the Cardiac Units from Emilia Romagna region. A workshop of IACPR/GICR - Emilia Romagna]
Massimo F Piepoli, Antonio Brambilla, Lorenzo Brambilla, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 13, 2018
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review
Alexander Vonbank, Heinz Drexel, Stefan Agewall, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 21, 2024
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023
Juan Tamargo, Stefan Agewall, Claudio Borghi, et al.
European Heart Journal
|
January 13, 2017
Comprehensive efforts to increase adherence to statin therapy
Alexander Vonbank, Stefan Agewall, Keld Per Kjeldsen, et al.
European Heart Journal
|
November 11, 2017
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Alexander Niessner, Juan Tamargo, Lorenz Koller, et al.
European Heart Journal
|
September 22, 2022
Sex differences in arterial hypertension
Eva Gerdts, Isabella Sudano, Sofie Brouwers, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 29, 2022
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Juan Tamargo, Keld Per Kjeldsen, Eva Delpón, et al.
Page
of 8